Maze Therapeutics, Inc.
MAZE
$9.07
-$0.25-2.68%
| Weiss Ratings | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -19.52% | |||
| 30-Day Total Return | -16.17% | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -43.13% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -46.65% | |||
| 52-Week Low % Change | 8.88% | |||
| Price | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $17.00 | |||
| 52-Week Low Price | $8.33 | |||
| 52-Week Low Price (Date) | Apr 04, 2025 | |||
| 52-Week High Price (Date) | Jan 31, 2025 | |||
| Valuation | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 397.23M | |||
| Enterprise Value | 735.13M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.08 | |||
| Earnings Per Share Growth | -54.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.13 | |||
| Price/Book (Q) | -0.07 | |||
| Enterprise Value/Revenue (TTM) | 4.39 | |||
| Price | $9.07 | |||
| Enterprise Value/EBITDA (TTM) | 12.07 | |||
| Enterprise Value/EBIT | 12.77 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.43M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 850 5070 | |||
| Address | 171 Oyster Point Blvd South San Francisco, CA 94080 | |||
| Website | www.mazetx.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 34.37% | |||
| Profit Margin | 31.18% | |||
| Management Effectiveness | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 23.07% | |||
| Return on Equity | 50.47% | |||
| Income Statement | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 167.50M | |||
| Total Revenue (TTM) | 167.50M | |||
| Revenue Per Share | $68.88 | |||
| Gross Profit (TTM) | 167.50M | |||
| EBITDA (TTM) | 60.88M | |||
| EBIT (TTM) | 57.59M | |||
| Net Income (TTM) | 52.23M | |||
| Net Income Avl. to Common (TTM) | 52.23M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -11.30% | |||
| EPS Diluted (TTM) | -2.08 | |||
| EPS Diluted Growth (Q YOY) | -94.57% | |||
| Balance Sheet | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 196.81M | |||
| Cash Per Share (Q) | $80.93 | |||
| Total Current Assets (Q) | 201.67M | |||
| Total Preferred Equity (Q) | 508.09 | |||
| Total Equity (Q) | 196.90M | |||
| Current Ratio (Q) | 9.755 | |||
| Book Value Per Share (Q) | -$127.72 | |||
| Total Assets (Q) | 240.54M | |||
| Total Current Liabilities (Q) | 20.67M | |||
| Total Debt (Q) | 26.63M | |||
| Total Liabilities (Q) | 43.64M | |||
| Total Common Equity (Q) | -311.18M | |||
| Cash Flow | MAZE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.15M | |||
| Cash from Financing (TTM) | 92.85M | |||
| Net Change in Cash (TTM) | 167.65M | |||
| Levered Free Cash Flow (TTM) | 8.51M | |||
| Cash from Operations (TTM) | 75.95M | |||
